Resonant Capital Advisors, LLC Dr Reddys Laboratories LTD Transaction History
Resonant Capital Advisors, LLC
- $1.69 Billion
- Q3 2025
A detailed history of Resonant Capital Advisors, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 15,006 shares of RDY stock, worth $201,980. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,006Holding current value
$201,980% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RDY
# of Institutions
255Shares Held
96.5MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$176 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$134 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$121 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.72MShares$90.4 Million26.28% of portfolio
-
Jpmorgan Chase & CO New York, NY6.03MShares$81.1 Million0.01% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.23B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...